Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
Clicks: 149
ID: 113830
2012
Abstract. Two recently completed phase 3 trials (003 and 004) showed fidaxomicin to be noninferior to vancomycin for curing Clostridium difficile infection (CD
| Reference Key |
w.2012clinicalfidaxomicin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Crook, Derrick W.;Walker, A. Sarah;Kean, Yin;Weiss, Karl;Cornely, Oliver A.;Miller, Mark A.;Esposito, Roberto;Louie, Thomas J.;Stoesser, Nicole E.;Young, Bernadette C.;Angus, Brian J.;Gorbach, Sherwood L.;Peto, Timothy E. A.;for the Study 003/004 Teams; |
| Journal | clinical infectious diseases |
| Year | 2012 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.